By Editor , 29 October 2026
Stepan Raises Quarterly Dividend to $0.405, 59th Straight Annual Increase

Northbrook, Illinois – October 28, 2026 -- Stepan Company (NYSE: SCL) has declared a quarterly cash dividend of $0.405 per share, extending its record of annual dividend increases to 59 consecutive years.

Stepan lifts the fourth-quarter 2026 payout by $0.010 per share

The board approved the increase in the fourth quarter of 2026. The dividend is payable on December 15, 2026, to common stockholders of record on December 1, 2026.

By Editor , 29 October 2026
Diebold Nixdorf Authorizes New $250 Million Share Buyback

North Canton, Ohio – October 28, 2026 -- Diebold Nixdorf (NYSE: DBD) said its Board of Directors authorized a new share repurchase program of up to $250 million, as the company's previous $200 million buyback, announced on Nov. 5, 2025, nears completion.

Executive Vice President and Chief Financial Officer Tom Timko said the new program gives the company "additional flexibility" to return capital to stockholders while it continues to invest in strategic opportunities across its businesses.

By Editor , 29 October 2026
AEP Lifts Capital Plan to $100B as Q3 Operating EPS Hits $2.23

Columbus – October 28, 2026 -- American Electric Power (Nasdaq: AEP) expanded its five-year capital plan to $100 billion through 2031 and said 2026 operating earnings will land at or above the high end of its $6.25 to $6.55 per share guidance range.

Third-quarter operating earnings rose to $1,216 million, or $2.23 per share, from $963 million, or $1.80 per share, a year earlier. GAAP earnings were $1,187 million, or $2.18 per share, against $972 million, or $1.82 per share, in the third quarter of 2025.

By Editor , 29 October 2026
Penske Automotive Q3 Revenue Rises 5% to $8.4B Ahead of Take-Private

Bloomfield Hills – October 28, 2026 -- Penske Automotive Group (NYSE: PAG) reported third-quarter revenue of $8.4 billion, up 5% from $8.1 billion a year earlier, and net income attributable to common stockholders of $220.8 million, or $3.36 per share. The results come as the company moves toward a take-private deal that values it at an enterprise value of about $16.3 billion.

By Editor , 29 October 2026
Dana Lifts Q3 EBITDA to $218M, Adds $100M Buyback

MAUMEE, Ohio – October 28, 2026 -- Dana Incorporated (NYSE: DAN) raised third-quarter adjusted EBITDA by $56 million to $218 million, lifting its margin 220 basis points to 10.7 percent. The supplier also announced an additional $100 million of share repurchases for the fourth quarter of 2026.

By Editor , 29 October 2026
Zocdoc Opens Booking Infrastructure to AI Agents, Adds Instinct

NEW YORK – October 28, 2026 -- Zocdoc said AI agent traffic on its platform has grown nearly 30x since July, and it is opening its healthcare access infrastructure to agents that find providers, verify insurance and book confirmed appointments on patients' behalf.

Agent traffic has doubled roughly every 10 days since early September, according to the company. Zocdoc is also adding the AI agent Instinct as a partner, giving it direct access to Zocdoc's MCP (Model Context Protocol) server.

By Editor , 29 October 2026
Exotec: 1 in 4 supply chain leaders regret automation choice

ATLANTA – October 28, 2026 -- One in four supply chain leaders wish they had chosen a different automation path, and 94% say switching providers would be prohibitively expensive, according to a survey of 250 North American decision-makers released by warehouse robotics provider Exotec. Most buyers are therefore locked into their chosen system for 10 to 15 years.

By Editor , 29 October 2026
Bold Security Named to 2027 Fortune Cyber 60 in First Year

New York – October 28, 2026 -- Bold Security, an endpoint data loss prevention (DLP) startup that has raised $40 million, has been named to the 2027 Fortune Cyber 60 in the early-stage category, its first year on the list.

By Editor , 29 October 2026

McLean, Va. – October 28, 2026 -- Aldrich Capital Partners (ACP) has made a strategic investment in TempusDirect, a provider of third-party claims cost containment solutions for the U.S. property and casualty (P&C) insurance industry, as the company enters its second decade.

By Editor , 29 October 2026
LUNGevity, Rising Tide Fund $620K EGFR Lung Cancer Resistance Trial

WASHINGTON – October 28, 2026 -- LUNGevity Foundation and the Rising Tide Foundation for Clinical Cancer Research (RTFCCR) have awarded $620,000 to an early-phase clinical trial at The Ohio State University Comprehensive Cancer Center. The trial will test whether pairing two FDA-approved drugs can stop resistance to osimertinib in EGFR-positive non-small cell lung cancer (NSCLC).